Takeda has made a strong play for a stake in the Alzheimer’s disease market, paying $100 million upfront for an option on AC Immune’s amyloid-targeting immunotherapy.

Evox Therapeutics is the second UK biotech to sign a big deal with a pharma giant this week, snaring an $882 million partnership with Takeda for up to five rare disease programmes. The alliance ...

View the latest Takeda Pharmaceutical Co. Ltd. ADR (TAK) stock price, news, historical charts, analyst ratings and financial information from WSJ.

A high-level overview of Takeda Pharmaceutical Company Limited (TAK) stock. View (TAK) real-time stock price, chart, news, analysis, analyst reviews and more.

An international team of researchers including Kavli IPMU has for the first time observed a new class of exotic atomic ...

Fujita won the 2025 NJPW Best of the Super Juniors tournament. He was next in line to challenge El Desperado for the IWGP Junior Heavyweight Championship, but Desperado was focused on his match ...

Get the annual and quarterly balance sheet of Takeda Pharmaceutical Company Limited (TAK) including details of assets, liabilities and shareholders' equity.

Last year, Takeda expanded its production base in Tianjin, and in the same year, Takeda launched its five-year development plan in China, Shan said. According to the plan, the company will launch at ...

As the Death Pain Invitational show date inches closer, new matches continue to be added to the lineup. Another tag team bout ...

New Japan Pro Wrestling has announced a tag team match for the NJPW Death Pain Invitational on June 24. The match will ...